SB INVESTMENT ADVISERS (UK) LTD 13D/13G Filings for Vir Biotechnology, Inc. (VIR)

SB INVESTMENT ADVISERS (UK) LTD 13D and 13G filings for Vir Biotechnology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-13
5:00 pm
Purchase
2023-12-3113GVir Biotechnology, Inc.
VIR
SB INVESTMENT ADVISERS (UK) LTD16,684,041
12.400%
16,684,041increase
(New Position)
Filing